Related Experiment Video

Updated: Jul 7, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Targeted cellular therapy with natural killer cells

H Klingemann1, L Boissel

  • 1Tufts-New England Medical Center, Boston, MA 02111, USA. hklingemann@tufts-nemc.org

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|February 20, 2008
PubMed

Insights

This study explores overcoming natural killer (NK) cell dysfunction in cancer patients. It investigates using allogeneic NK cells, Fc receptor-selected NK cells with antibodies, and genetically engineered NK cells to enhance anti-tumor immunity.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Therapy

Background:

  • Natural killer (NK) cells are crucial for anti-cancer immunity.
  • Cancer patients often exhibit impaired NK cell function.
  • Tumor cells develop mechanisms to evade NK cell recognition and killing.

Purpose of the Study:

  • To overcome NK cell paralysis in cancer patients.
  • To enhance the efficacy of adoptive immunotherapy using NK cells.
  • To develop novel strategies for NK cell-mediated cancer treatment.

Main Methods:

  • Utilizing allogeneic natural killer (NK) cells to bypass self-histocompatibility antigen inhibition.
  • Employing NK cells with high-affinity Fc receptors in conjunction with monoclonal antibodies to induce antibody-dependent cellular cytotoxicity (ADCC).
  • Genetically engineering NK cells to express chimeric antigen receptors (CARs) for targeted tumor cell lysis.

Main Results:

  • Allogeneic NK cells are not inhibited by self-histocompatibility antigens, offering a potential therapeutic advantage.
  • NK cell-mediated ADCC, enhanced by high-affinity Fc receptors and monoclonal antibodies, can overcome tumor escape mechanisms.
  • Chimeric antigen receptor (CAR)-engineered NK cells demonstrate the ability to recognize tumor-specific antigens and induce tumor cell killing, bypassing inhibitory signals.

Conclusions:

  • Adoptive immunotherapy with allogeneic NK cells presents a promising strategy to overcome NK cell defects in cancer.
  • Combining NK cells with monoclonal antibodies or genetic engineering (CARs) can restore and enhance their anti-tumor activity.
  • These approaches offer novel avenues for developing effective NK cell-based cancer immunotherapies.

More Related Videos

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...